# A Randomised, Double-Blind, Placebo-Controlled Study Assessing the Effect of Fenofibrate, Coenzyme Q10 and Their co-Administration on Ventricular Diastolic Function in Patients With Type 2 Diabetes

> **NCT00703482** · PHASE2 · COMPLETED · sponsor: **Solvay Pharmaceuticals** · enrollment: 278 (actual)

## Conditions studied

- Patients With Type 2 Diabetes

## Interventions

- **DRUG:** Fenofibrate/CoQ10
- **DRUG:** Fenofibrate/CoQ10
- **DRUG:** Fenofibrate/CoQ10
- **DRUG:** Fenofibrate/CoQ10
- **DRUG:** Fenofibrate/CoQ10
- **DRUG:** Fenofibrate/CoQ10
- **DRUG:** Fenofibrate/CoQ10

## Key facts

- **NCT ID:** NCT00703482
- **Lead sponsor:** Solvay Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-05
- **Primary completion:** 2004-09
- **Final completion:** 2004-09
- **Target enrollment:** 278 (ACTUAL)
- **Last updated:** 2008-06-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00703482

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00703482, "A Randomised, Double-Blind, Placebo-Controlled Study Assessing the Effect of Fenofibrate, Coenzyme Q10 and Their co-Administration on Ventricular Diastolic Function in Patients With Type 2 Diabetes". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00703482. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*